Topics

CNS Tumors | Etiopathogenesis | Resistance

Home > Publications > Topics > CNS Tumors > Etiopathogenesis > Resistance

2025

Wang Y, Bai H, Wang A, Zhao J, Guo H, Tang Y, Wang Y, Xie Q.
Reviewing the IDH1 Mutation-Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies.
Chem Biol Drug Des. 2025 Apr 4;105(4):e70102. doi: 10.1111/cbdd.70102. PMID: 40183465. Review˰ ˍ

2026

Zhou L, Luo X, Bao T, Sun H, He C, Yang Y, Xia Y.
Neurobiology of cancer: Unraveling the roles of the nervous system in tumor initiation, progression, and therapeutic.
Chin Med J (Engl). 2026 Jun 16. doi: 10.1097/CM9.0000000000004144. PMID: 42299464. ˍ

Beniwal SS, Ribeiro da Costa REA, Hanchate AA, Mwaanga C, Özge Çelik E, Mishra A.
Beyond the mutation: integrating radiogenomics, epigenetics, and immune signatures to overcome therapeutic resistance in CNS tumors: a narrative review.
Ann Med Surg (Lond). 2026 Jul 15;88(8):5183-5194. doi: 10.1097/MS9.0000000000005291. PMID: 42583540. ˍ